4.710USD+0.64%Mkt Cap: 336.03M USDP/E: 16.73Last update: 2026-05-26
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox d…
Industry Peers
Drug Manufacturers - Specialty & GenericIndicators:|
Key Statistics
Company
Market Cap336.03M USD
Enterprise Value192.86M USD
Revenue (TTM)93.78M USD
Gross Profit64.87M USD
Net Income (TTM)23.28M USD
Revenue/Share1.310 USD
Last Price4.710 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees49
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)16.73
P/E (Forward)4.49
PEG3.37
EV/EBITDA9.09
EV/Revenue2.06
P/S3.60
P/B1.70
EPS (TTM)0.28
EPS (Forward)1.05
52W Range
4.10011% of range9.620
52W High9.620 USD
52W Low4.100 USD
Profitability
Gross Margin68.59%
Oper. Margin-85.24%
EBITDA Margin22.62%
Profit Margin24.61%
ROE11.71%
ROA10.61%
Growth
Revenue Growth-11.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF43.47M USD
CapEx (TTM)355.01K USD
FCF Margin63.39%
FCF Yield17.69%
Net Debt-144.96M USD
Net Debt/EBITDA-6.83
Balance Sheet
Debt/Equity0.00
Current Ratio3.25
Quick Ratio2.30
Book Value/Sh2.776 USD
Cash/Share2.029 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateApr 7, 2026
Pay DateApr 23, 2026
Analyst Consensus
Rating0.0 (Hold)
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.71.72M
Float41.12M
Insiders42.66%
Institutions49.63%
Short Interest
Short Ratio5.1d
Short % Float7.19%
Short % Out.4.65%
Shares Short3.34M
Short (prev mo.)3.48M
Technical
SMA 504.743 (-0.7%)
SMA 2006.713 (-29.8%)
Beta0.85
S&P 52W Chg28.31%
Avg Vol (30d)508.75K
Avg Vol (10d)681.98K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—